Login to Your Account



$3.2B AVAILABLE FOR R&D PROPOSALS

China renews efforts to spur innovation; HIV/AIDS a top priority

By Kristine Yang
Staff Writer

Wednesday, March 26, 2014

HONG KONG – Over the next year, health authorities in China plan to renew their focus on biotech development and continue funding research and development of new drugs to the tune of $3.2 billion.

To continue reading subscribe now to BioWorld Asia (formerly International)

Learn More about BioWorld Asia (formerly International)

Already a subscriber? Sign In or Buy now to activate your subscription